Form 4: Roivant Sciences Director Sells Shares

Sentiment:

Insider Transaction (Form 4)


Melissa B Epperly, a Director of Roivant Sciences Ltd., sold 17,750 shares of common stock on October 1, 2026.

Summary

  • Option exercise/conversion: acquired 17,750 Common Shares at $4.46 ($79,165) on October 1, 2026; holds 32,704 after (Direct).
  • Open-market sale: disposed of 16,850 Common Shares at $36.08 ($607,948) on October 1, 2026; holds 15,854 after (Direct).
  • Open-market sale: disposed of 900 Common Shares at $36.57 ($32,913) on October 1, 2026; holds 14,954 after (Direct).
  • Option exercise/conversion: disposed of 17,750 Stock Option (Right to Buy) on October 1, 2026; holds 151,416 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $640,861 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Melissa B Epperly โ€” Director

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-10-01Option exercise/conversionCommon Shares17,750$4$79.2K32,704
2026-10-01Open-market saleCommon Shares16,850$36$607.9K15,854
2026-10-01Open-market saleCommon Shares900$37$32.9K14,954
2026-10-01Option exercise/conversionStock Option (Right to Buy)17,750โ€”โ€”151,416

Key Dates

DateDescription
2026-10-01Option exercise/conversion (17,750 shares)
2026-10-01Open-market sale (16,850 shares)
2026-10-01Open-market sale (900 shares)
2026-10-01Option exercise/conversion (17,750 shares)

Keywords

insider transaction, Form 4, ROIV, Roivant Sciences Ltd., bearish, Melissa B Epperly

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.